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doi:10.1Objective: The study objectivewas to determinewhether the vasculopathy seen in nonobstructed lung regions in
chronic thromboembolic pulmonary hypertension is induced by the local blood flow increase or by factors
released by the ischemic lung.
Methods: Three groups of 10 piglets were studied 5 weeks after right pulmonary artery ligation, right pneumo-
nectomy, or right pulmonary artery dissection (sham). Pulmonary vascular resistance, pulmonary arterial vaso-
reactivity, andmorphometry were measured, and gene expressions of factors involved in vascular smooth muscle
cell proliferation were quantified.
Results: Left lung blood flow was similarly increased after right pneumonectomy and right pulmonary artery
ligation. Compared with right pneumonectomy, right pulmonary artery ligation resulted in left lung vasculop-
athy with increased pulmonary vascular resistance (P ¼ .0009), medial hypertrophy of the distal pulmonary ar-
tery (P<.0001), and decreases in maximal relaxation to acetylcholine (P ¼ .013) and endothelial nitric oxide
synthase gene expression (P¼ .041). These values were similar after sham and right pneumonectomy. In the left
lung, right pulmonary artery ligation increased the gene expressions for insulin-like growth factor (P ¼ .034),
platelet-derived growth factor (P ¼ .0006), and vascular endothelial growth factor (P ¼ .0105) compared with
right pneumonectomy and sham. Whereas endothelin-1 gene expression was not affected, expressions of
endothelin-1 receptors A and Bwere downregulated after right pneumonectomy (P¼ .048 and P¼ .039, respec-
tively) and right pulmonary artery ligation (P ¼ .033 and P ¼ .028, respectively).
Conclusions: Pulmonary vasculopathy was absent in the remaining lung 5 weeks after right pneumonectomy
but developed in the nonobstructed lung regions 5 weeks after right pulmonary artery ligation, suggesting
that factors released by the ischemic lung induced vascular remodeling in the contralateral lung. This endocrine
process may involve the release of factors involved in vascular smooth muscle cell proliferation. (J Thorac Car-
diovasc Surg 2012;143:967-73)Chronic thromboembolic pulmonary hypertension
(CTEPH) is a rare and life-threatening disease in which or-
ganized thromboemboli obstruct the pulmonary arteries
(PAs) and pulmonary vascular remodeling develops in the
nonobstructed lung regions. These abnormalities increase
the pulmonary vascular resistance, causing pulmonary hy-
pertension (PH) and progressive right-sided heart failure.
The mechanisms underlying the vascular remodeling in
the nonobstructed PAs are unknown.
After acute pulmonary embolism, the obstructed vascular
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Snonobstructed vascular territories are exposed to high shear
stress resulting from redistribution of the pulmonary blood
flow.1 Whether the pulmonary vascular remodeling is re-
lated to increased pulmonary blood flow has been investi-
gated in various animal models. Consistent with data
reported by several authors,2-4 our previous study in a pig
model demonstrated that increased pulmonary blood flow
for 5 weeks due to an aortopulmonary shunt induced
pulmonary vasculopathy with medial hypertrophy of the
distal PAs caused by smooth muscle cell (SMC)
proliferation, impaired endothelium-dependent vasorelaxa-
tion, and increased expression of endothelin (ET)-1, ET re-
ceptor A (ETA), angiopoietin-1, angiopoietin-2, and Tie-2
in the lung parenchyma.1 However, these animal models
do not accurately replicate human CTEPH because they
do not induce chronic lung ischemia, which may be in-
volved in the development of vasculopathy in the nonob-
structed lung territories.
We hypothesized that endocrine factors released by the
ischemic lung might account for the development of pulmo-
nary vasculopathy in nonobstructed regions. To test this hy-
pothesis, we studied the effects of chronic high blood flow
due to cardiac output redistribution to the left lung afterrdiovascular Surgery c Volume 143, Number 4 967
Abbreviations and Acronyms
CTEPH ¼ chronic thromboembolic pulmonary
hypertension
eNOS ¼ endothelial nitric oxide synthase
ET ¼ endothelin
ETA ¼ endothelin receptor A
ETB ¼ endothelin receptor B
IGF ¼ insulin-like growth factor
NO ¼ nitric oxide
PA ¼ pulmonary artery
PBS ¼ phosphate-buffered saline
PCNA ¼ proliferating cell nuclear antigen
PDGF ¼ platelet-derived growth factor
PH ¼ pulmonary hypertension
SMC ¼ smooth muscle cell




Sright pneumonectomy or right PA ligation in pigs to model
blood flow redistribution combined with contralateral is-
chemia. Sham-operated animals served as controls. We in-
vestigated the angiogenic, ET, and nitric oxide (NO)
pathways to look for underlying pathophysiologic
mechanisms.
MATERIALS AND METHODS
Thirty Large White piglets weighing 22  4 kg were used. The study
complied with the Principles of Laboratory Animal Care developed by
the National Society for Medical Research, and the Guide for the Care
and Use of Laboratory Animals written by the Institute of Laboratory An-
imal Resources and published by the National Institutes of Health (publi-
cation no. 86-23, revised in 1985).
Study Groups
The piglets were randomly allocated to 3 groups of 10 animals each. The
studies were done 5 weeks after right PA ligation (ligated group), right
pneumonectomy (pneumonectomy group), or a sham operation consisting
only in dissection of the right PA (sham group).
Surgical Procedure
Anesthesia was induced with intramuscular ketamine (100 mg/kg) and
maintained with intravenous pentobarbital (10 mg/kg bolus, followed by
a continuous infusion of 0.1 mg/kg/min). The animals were paralyzed
with pancuronium (0.3 mg/kg). After endotracheal intubation, intermittent
positive-pressure ventilation was provided (MMS RET 107 ventilator;
MMS, Pau, France) at a tidal volume of 15 mL/kg, with a respiratory
rate of 18 cycles/min and a fraction of inspired oxygen of 0.5. Body tem-
perature was maintained at 37C.
With the animal in the supine position, a midline sternotomy was per-
formed under sterile conditions, and the pericardium was opened. For right
PA ligation, the right PAwas approached after retracting the superior vena
cava andmobilizing the ascending aorta and was ligated using a nonabsorb-
able loop. For right pneumonectomy, the same approach was used and the
right PAwas ligated and divided. The right pleura was then opened to allow
division of the upper and lower pulmonary veins and right bronchus. The
right lung was removed without chest drainage. In the sham group, the ap-
proach was the same but the right PAwas merely dissected. After the pro-
cedure, the chest was closed and the animal was allowed to recover.968 The Journal of Thoracic and Cardiovascular SurgTissue Preparation
Five weeks later, the pigs were anesthetized as described above. A mid-
line sternotomy was performed. After heparin administration, the animal
was killed by exsanguination and the left lung was rapidly removed from
the chest. The left PAwas then flushed with 500 mL of 0.9% normal saline
solution. Biopsy specimens weighing 300 to 500 mg were taken from the
left upper lobe, snap-frozen in liquid nitrogen, and stored at70C or fixed
in 4% paraformaldehyde solution.
Hemodynamic Measurements
Pulmonary and systemic hemodynamic variables were measured before
the animals were killed. Aortic and pulmonary blood flow were measured
using a flow probe (Transonic Systems, Inc, Ithaca, NY) placed on the or-
igins of the aorta and pulmonary trunk. Pressures and blood gases were
measured by direct puncture at the origins of the aorta and left PA. Total
pulmonary resistance was calculated as mean PA pressure divided by
flow (Q).
Light Microscopy and Morphometry
Fixed lung sections were processed using standard histologic techniques
and embedded in paraffin. We sought to identify 30 to 40 arteries less than
200 mm in diameter in each piglet.Medial thickness (MT)was calculated as
follows:
%MT ¼ ðEDIDÞ3 100=ED
where ED is the external diameter and ID the internal diameter.
Evaluation of In Situ Pulmonary Artery Small
Muscle Cell Proliferation
To assess the PA-SMC proliferation, the proliferating cell nuclear anti-
gen (PCNA) was evaluated. Tissue sections were deparaffinized in xylene,
treated with a graded series of alcohol washes, rehydrated in phosphate-
buffered saline (PBS) (pH 7.5), and incubated with target retrieval solution
(Dako, Trappes, France) into a water bath at 90C for 20 minutes. Endog-
enous peroxidase activity was blocked using hydrogen peroxide in PBS
(3% vol/vol) for 5 minutes. Slides were then washed in PBS and incubated
for 30 minutes in a protein-blocking solution consisting of PBS supple-
mented with 3% bovine serum albumin. The slides were subsequently
incubated for 30 minutes with anti-PCNA mouse monoclonal antibody
(PC-10, 1:200; Dako, France). Antibodies were washed off and the slides
were processed using the alkaline phosphatase LSABþSystem-HRPDetec-
tion Kit (DAKO, Carpinteria, Calif). Brown color was generated by using
a diaminobenzidine substrate, and nuclei were counterstained with
hematoxylin.
Pulmonary Artery Reactivity
At the end of the study, intrapulmonary arterial segments were dissected
out and endothelial relaxation was investigated as described previously.5
Acetylcholine hydrochloride, calcium ionophore A23187, and sodium ni-
troprusside were used for relaxation after phenylephrine precontraction.
The drugs used to assess PA reactivity were purchased from Sigma Chem-
ical Company (St Louis, Mo).
Real-Time Quantification by Polymerase Chain
Reaction Assay
Real-time polymerase chain reaction was conducted as previously
described.6 Except for platelet-derived growth factor (PDGF) and
insulin-like growth factor (IGF), we used specific porcine primers previ-
ously described by Rondelet and associates6 (vascular endothelial growth
factor [VEGF], ET-1, ET-1 receptors ETA and ETB, and endothelial nitric
oxide synthase [eNOS]). The primers for IGF-1 and PDGF had been used inery c April 2012
Sage et al Evolving Technology/Basic Scienceour laboratory for human experimentation and were designed on Primer
Express software (Applied Biosystems, Foster City, Calif).
To avoid inappropriate amplification of residual genomic DNA, intron-
spanning primers were selected and internal control 18S rRNA (r18S)
primers provided. For each sample, the amplification reaction was per-
formed in duplicate using SYBR Green mix (Applied Biosystems) and
specific primers. Signal detection and result analysis were achieved using
ABI-Prism 7000 sequence detection software (Applied Biosystems).
Expression of the gene of interest was computed relative to expression of
the internal standard mRNA, r18S, using the following formula:
relative mRNA ¼ 1=2ðCtgene of interestCtr18SÞ.
Statistical Analysis
Data are described as means  standard error of the mean. Analysis of
variance followed by the Fisher test for multiple comparisons was per-
formed using the StatView software package version 5 (Abacus Concept,
Berkeley, Calif).RESULTS
Hemodynamic Variables
None of the piglets died prematurely. Heart rate and
mean arterial pressure were not significantly different
across the groups. Mean PA pressure was significantly ele-
vated in the ligated group (16.2  1.3 mm Hg) compared
with the pneumonectomy (11.6  0.7 mm Hg; P ¼ .0069)
and sham (13.0 0.7 mm Hg; P¼ .0447) groups; this vari-
able was not significantly different between the sham and
pneumonectomy groups.
Mean absolute cardiac output was significantly decreased
in the ligated group (1.53 0.06 L/min) compared with the
sham group (2.04 0.13 L/min; P¼ .0265) but was not dif-
ferent between the ligated and pneumonectomy groups (1.8
 0.23 L/min).
Total pulmonary resistance was significantly higher in
the ligated group (10.05  0.69 Wood units) than in the
pneumonectomy (6.83  0.51 Wood units; P ¼ .0009)
and sham 6.48  0.59 Wood units; P ¼ .0004) groups.




SPulmonary Vascular Remodeling in the Left Lung
In the sham group, medial wall thickness of PAs less than
200 mm in diameter was 22.9%  0.7%. Five weeks after
right PA ligation, medial wall thickness was significantly
increased compared with the pneumonectomy (42.3% 
1.1% vs 21.8%  0.7%; P<.0001) and sham (42.3% 
1.1% vs 22.9%  0.7%; P<.0001) values. Medial wall
thickness was not significantly changed after pneumonec-
tomy compared with the sham procedure (21.8%  0.7%
vs 22.9% 0.7%; P¼ .29). Plexiform lesions were not ob-
served in any group (Figures 1, A and B, and 2).
PCNA labeling demonstrated a significant proliferation
of SMCs in the distal PAwall in ligated animals. Fiveweeks
after right PA ligation, the number of PCNA positive cells
increased markedly in the left lung when compared with
sham values (32.4%  11% vs 8%  9%, P < .05).The Journal of Thoracic and CaConversely, 5 weeks after right pneumonectomy, the num-
ber of PCNA positive cells in the remaining lung (13% 
11%, P ¼ not significant) was similar to sham values
(Figure 2).
Pulmonary Vascular Reactivity and Endothelial
Function of the Left Lung
Contraction of PA rings in response to phenylephrine was
similar in all 3 groups. The relaxation response to sodium
nitroprusside was not affected by right pneumonectomy or
right PA ligation. Maximal relaxation in response to acetyl-
choline was significantly decreased in the ligated group
compared with the pneumonectomy (60.3%  4.6% vs
83.5%  3.5%; P ¼ .0157) and sham (60.3%  4.6% vs
91.3%  5.9%; P ¼ .0139) groups. Pneumonectomy did
not significantly modify maximal relaxation in response
to acetylcholine (83.5%  3.5% vs 91.3%  5.9%;
P ¼ .31) (Figure 3).
Expression of Genes Involved in the Endothelin-1,
Nitric Oxide Synthase, and Angiogenesis Pathways in
the Left Lung
Compared with the sham group, the ligated group ex-
hibited significant downregulation of eNOS gene expres-
sion (P ¼ .041). A trend toward decreased eNOS mRNA
levels was found in the pneumonectomy group. There was
no significant difference between the pneumonectomy and
ligated groups (Figure 4).
Whereas ET-1 gene expression was not affected by the
experimental procedures, ETA and ETB expressions were
similarly downregulated in the pneumonectomy group
(P¼ .048 and P¼ .039, respectively) and the ligated group
(P ¼ .033 and P ¼ .028, respectively) compared with the
sham group (Figure 5).
As shown in Figure 6, left lung PDGF and VEGF gene
expressions were increased in the pneumonectomy group
compared with the sham group. The expression of these
proangiogenic factors was significantly greater in the li-
gated group than in the pneumonectomy and sham groups.
Left lung IGF gene expression was increased in the ligated
group compared with both the sham and the pneumonec-
tomy groups.
DISCUSSION
We found that right PA ligation for 5 weeks induced vas-
cular remodeling in the left lung with increases in pulmo-
nary vascular resistance and medial thickness of distal
PAs, impaired endothelium-dependent vasorelaxation, and
decreased eNOS gene expression. By contrast, 5 weeks af-
ter right pneumonectomy, no evidence of pulmonary vas-
culopathy was found in the left lung, where the
hemodynamics, morphology, and NO pathway were similar
to those in the sham animals. Of note, ligation was followed
by upregulation of the expressions of the proangiogenicrdiovascular Surgery c Volume 143, Number 4 969
FIGURE 1. A, Morphometry (3400) of PAs less than 200 mm diameter in the sham, pneumonectomy group, and ligated groups. The percentage of media
thickness was highest in the ligated group (P<.05). B, Box plot of the percentage of media thickness of small PAs (<150 mm) 5 weeks after a sham pro-
cedure, right PA ligation, or right pneumonectomy. MT, Medial thickness; ET, external diameter; ID, internal diameter.




Sfactors IGF, PDGF, and VEGF. Because elevated shear
stress affected the left lung similarly after right PA ligation
and right pneumonectomy, this result suggests that the is-
chemic lung released factors that induced vascular remodel-
ing in the nonobstructed PA tree, thereby contributing to
increase the pulmonary vascular resistance.
CTEPH typically develops after 1 or more episodes of
pulmonary embolism due to deep vein thrombosis.7 Failure970 The Journal of Thoracic and Cardiovascular Surgof the emboli to resolve leads to segmental obstruction of
the corresponding vascular areas with blood redistribution
to nonobstructed areas and the progressive development
of PH. The structural changes that are thought to underlie
the increased pulmonary vascular resistance in CTEPH
can be broadly classified as related to 2 different processes:
(1) a reduction in the total number of blood vessels in the
lung and (2) remodeling of the nonobstructed pulmonaryery c April 2012
FIGURE 2. Evaluation of in situ PA-SMC proliferation as assessed by PCNA coloration in the left lung of sham, ligated, and pneumonectomy groups. PA
wall thickness in the left lung 5 weeks after right PA ligation is related to the proliferation of SMCs.
Sage et al Evolving Technology/Basic Scienceresistance vessels.1,7-10 Two mechanisms have been
suggested to explain the development of distal
vasculopathy in nonobstructed regions, namely, prolonged
excessive shear stress due to blood flow redistribution and
chronic vascular release of proinflammatory and
angiogenic mediators by ischemic lung tissue. ToFIGURE 3. Vasoconstriction to ET-1 and relaxation to acetylcholine of
PA rings from the sham, ligated, and pneumonectomy groups. Ligation
of the right PA for 5 weeks induced a decrease inmaximal relaxation to ace-
tylcholine in the contralateral lung. In contrast, 5 weeks after right pneumo-
nectomy left lung maximal relaxation was similar to that in sham-operated
animals.
The Journal of Thoracic and Cainvestigate the respective roles for these 2 mechanisms,
we compared 2 animal models characterized by chronic
shear stress elevation without (right pneumonectomy) or
with (right PA ligation) lung ischemia. Consistent with
previous animal studies and clinical experience, PH and
pulmonary vascular remodeling did not occur after right
pneumonectomy in our study.11-13 Indeed,
pneumonectomy directs the entire cardiac output to theFIGURE 4. eNOS mRNA quantification in the left lung parenchyma by
real-time polymerase chain reaction. Expression of eNOS was decreased
5 weeks after right PA ligation but remained unchanged 5 weeks after right
pneumonectomy. eNOS, Endothelial nitric oxide synthase.





FIGURE 5. Quantification of mRNAs for ET-1 and its receptors (ETA and ETB) in left lung parenchyma by real-time polymerase chain reaction. Whereas
ET-1 expression remained unchanged, ETA and ETB mRNA levels were decreased in the contralateral lung 5 weeks after right PA ligation or right pneu-
monectomy. ET-1, Endothelin-1; ETA, endothelin receptor A; ETB, endothelin receptor B.




Sremaining lung resulting in transient increase of PA
pressure, and in under normal circumstances, this value
returns to baseline level despite amputation of half of the
PA bed.11 Several adaptive mechanisms protect the pulmo-
nary vascular bed from the consequences of increased shear
stress under these conditions, including vascular dilatation
and distention involving upregulation of the NO pathway
in the first 2 postoperative weeks.11 Our finding of normal
eNOS expression 5 weeks after pneumonectomy confirms
the transient role for NO in inducing vascular bed
adaptation. By contrast, 3 growth factors (VEGF, PDGF,
and IGF-1) remained upregulated in our study, as
previously reported.14-16 The involvement of ET in
vascular function after pneumonectomy is less clear.
Onizuka and colleagues17,18 described a transient increase
in ET-1 levels after thoracic surgery in humans, with nor-
malization within 72 hours. Although ET-1 expression
was normal 5 weeks after pneumonectomy in our study,
ETA and ETB expressions were decreased. This persistent
downregulation of the ET pathway may have prevented pul-
monary vascular remodeling after pneumonectomy. Indeed,
in a previous study in pigs, we showed that pulmonary high
flow induced by 5 weeks of aortopulmonary shuntingFIGURE 6. Quantification of mRNAs for IGF, PDGF, and VEGF in left lung p
PDGF and VEGF gene expressions were increased in the pneumonectomy group
was greater in the ligated group than in the pneumonectomy and sham groups. L
with both the sham and the pneumonectomy groups. IGF, Insulin-like growth
growth factor.
972 The Journal of Thoracic and Cardiovascular Surgresulted in distal pulmonary vasculopathy associated with
ETA upregulation. Moreover, anti-ETA therapy accelerated
the reversal of the flow-induced PA disease after flow cor-
rection.19 These data suggested a role for both the NO
and the ET pathways in preventing vascular remodeling af-
ter pneumonectomy. They also indicated that pulmonary
blood flow redistribution to nonobstructed PAs, inducing in-
creases in shear stress and PA pressures, could not fully ex-
plain the development of distal pulmonary vasculopathy. By
contrast, in CTEPH, pulmonary vascular resistances are not
correlated to the degree of proximal anatomic obstruction as
assessed by pulmonary angiography or perfusion nuclear
scan. Indeed, a low anatomic obstruction (less than half of
the PA bed) can be associated in some patients with high
pulmonary resistance.9 This subgroup of patients with
‘‘out of proportion PH’’ are at high risk for surgery. Thus,
there was substantial evidence supporting a major role for
the ischemic lung in the development of pulmonary vascu-
lar remodeling in nonobstructed PAs with subsequent PH.
In our model of right PA ligation, blood flow redistribu-
tion to the left lung combined with contralateral lung ische-
mia for 5 weeks resulted in pulmonary vasculopathy with
increases in pulmonary vascular resistance and distal PAarenchyma from the sham operation, ligation, and pneumonectomy groups.
compared with the sham group. Expression of these proangiogenic factors
eft lung IGF gene expression was increased in the ligated group compared
factor; PDGF, platelet-derived growth factor; VEGF, vascular endothelial
ery c April 2012
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dependent vasorelaxation. Left lung ligation has been ex-
tensively used to study the mechanisms of postobstructive
pulmonary vasculopathy.20 We and others consistently
found that chronic lung ischemia was associated with upre-
gulation of angiogenic growth factors, leading to the devel-
opment of an exuberant systemic blood supply to the
ischemic lung.20-22 However, our present finding of
contralateral vasculopathy had not been documented
previously in the PA ligation model. This finding is not
surprising given the marked increases in the expressions
of 3 important proangiogenic factors, namely, VEGF,
PDGF, and IGF, in the nonischemic lung 5 weeks after
right PA ligation. These increases suggest that the
ischemic lung may release endocrine factors that
stimulate the expression of these 3 genes. Our results are
consistent with previously reported studies on the role of
proangiogenic factors in the development of pulmonary
vasculopathy. Thus, VEGF was strongly expressed in
pulmonary angioproliferative plexiform lesions from
patients with severe idiopathic or secondary PH.23 Like-
wise, our group showed previously that PDGF played a ma-
jor role in the proliferation and migration of PA SMCs in
human PH.24 IGF is also known as an important activator
of PA SMC proliferation.25 These peptides may constitute
targets for treatments designed to prevent pulmonary vas-
culopathy in selected patients with severe CTEPH.
CONCLUSIONS
Chronic lung ischemia plays a key role in the develop-
ment of pulmonary vasculopathy in nonobstructed pulmo-
nary territories. In our study, pulmonary vasculopathy was
absent in the remaining lung 5 weeks after pneumonectomy
but developed in the nonobstructed pulmonary territories 5
weeks after right PA ligation, suggesting that factors re-
leased by the ischemic lung induced vascular remodeling
in the contralateral lung. These endocrine factors may be
factors involved in vascular SMC proliferation.
References
1. Mercier O, Sage E, de Perrot M, Tu L, Marcos E, Decante B, et al. Regression of
flow-induced pulmonary arterial vasculopathy after flow correction in piglets. J
Thorac Cardiovasc Surg. 2009;137:1538-46.
2. Muller WJ, Dammann JJ, Head WJ. Changes in the pulmonary vessels produced
by experimental pulmonary hypertension. Surgery. 1953;34:363-75.
3. Rendas A, Lennox S, Reid L. Aorta-pulmonary shunts in growing pigs. Func-
tional and structural assessment of the changes in the pulmonary circulation. J
Thorac Cardiovasc Surg. 1979;77:109-18.The Journal of Thoracic and Ca4. Fike C, Kaplowitz M, Bousamra MN. eNOS and prostanoid enzymes in lungs of
newborn piglets with chronic aortopulmonary shunts. Am J Physiol Lung Cell
Mol Physiol. 2001;281:L475-82.
5. Fadel E, Mazmanian G, Baudet B, Detruit H, Verhoye J, Cron J, et al. Endothelial
nitric oxide synthase function in pig lung after chronic pulmonary artery obstruc-
tion. Am J Respir Crit Care Med. 2000;162(4 Pt 1):1429-34.
6. Rondelet B, Kerbaul F, Motte S, van Beneden R, Remmelink M, Brimioulle S,
et al. Bosentan for the prevention of overcirculation-induced experimental pul-
monary arterial hypertension. Circulation. 2003;107:1329-35.
7. Moser K, AugerW, Fedullo P. Chronic major-vessel thromboembolic pulmonary
hypertension. Circulation. 1990;81:1735-43.
8. Peacock A, Simonneau G, Rubin L. Controversies, uncertainties and future re-
search on the treatment of chronic thromboembolic pulmonary hypertension.
Proc Am Thorac Soc. 2006;3:608-14.
9. Dartevelle P, Fadel E,Mussot S, Chapelier A, Herve P, de Perrot M, et al. Chronic
thromboembolic pulmonary hypertension. Eur Respir J. 2004;23:637-48.
10. Hoeper MM, Rubin LJ. Update in pulmonary hypertension 2005. Am J Respir
Crit Care Med. 2006;173:499-505.
11. Maxey T, Fernandez L, Reece T, Keeling W, Kron I, Laubach V. Endothelial ni-
tric oxide synthase is essential for postpneumonectomy compensatory vasodila-
tion. Ann Thorac Surg. 2006;81:1234-8.
12. Johnson RJ, Cassidy S, Grover R, Ramanathan M, Estrera A, Reynolds R, et al.
Effect of pneumonectomy on the remaining lung in dogs. J Appl Physiol. 1991;
70:849-58.
13. Friedli B, Kent G, Kidd B. The effect of increased pulmonary blood flow on the
pulmonary vascular bed in pigs. Pediatr Res. 1975;9:547-53.
14. McAnulty RJ, Guerreiro D, Cambrey AD, Laurent GJ. Growth factor activity in
the lung during compensatory growth after pneumonectomy: evidence of a role
for IGF-1. Eur Respir J. 1992;5:739-47.
15. Yuan S, HannamV, Belcastro R, Cartel N, Cabacungan J, Wang J, et al. A role for
platelet-derived growth factor-BB in rat postpneumonectomy compensatory lung
growth. Pediatr Res. 2002;52:25-33.
16. Jancelewicz T, Grethel EJ, Chapin CJ, Clifton MS, Nobuhara KK. Vascular en-
dothelial growth factor isoform and receptor expression during compensatory
lung growth. J Surg Res. 2010;160:107-13.
17. Onizuka M, Miyauchi T, Mitsui K, Suzuki N, Masaki T, Goto K, et al. Endothe-
lin-1 mediates regional blood flow during and after pulmonary operations.
J Thorac Cardiovasc Surg. 1992;104:1696-701.
18. OnizukaM,Miyauchi T,Morita R, Akaogi E,Mitsui K, Suzuki N, et al. Increased
plasma concentrations of endothelin-1 during and after pulmonary surgery.
J Cardiovasc Pharmacol. 1991;17(Suppl 7):S402-3.
19. Mercier O, Sage E, Izziki M, Humbert M, Dartevelle P, Eddahibi S, et al. Endo-
thelin A receptor blockade improves regression of flow-induced pulmonary vas-
culopathy in piglets. J Thorac Cardiovasc Surg. 2010;140:677-83.
20. Fadel E, Michel R, Eddahibi S, Bernatchez R, Mazmanian G, Baudet B, et al. Re-
gression of postobstructive vasculopathy after revascularization of chronically
obstructed pulmonary artery. J Thorac Cardiovasc Surg. 2004;127:1009-17.
21. Charan NB, Carvalho P. Angiogenesis in bronchial circulatory system after uni-
lateral pulmonary artery obstruction. J Appl Physiol. 1997;82:284-91.
22. Michel RP, Hakim TS. Increased resistance in postobstructive pulmonary vascul-
opathy: structure-function relationships. J Appl Physiol. 1991;71:601-10.
23. Voelkel N, Vandivier R, Tuder R. Vascular endothelial growth factor in the lung.
Am J Physiol Lung Cell Mol Physiol. 2006;290:L209-21.
24. Perros F, Montani D, Dorfmuller P, Durand-Gasselin I, Tcherakian C, Le
Pavec J, et al. Platelet-derived growth factor expression and function in idio-
pathic pulmonary arterial hypertension. Am J Respir Crit Care Med. 2008;
178:81-8.
25. Dempsey EC, Stenmark KR, McMurtry IF, O’Brien RF, Voelkel NF,
Badesch DB. Insulin-like growth factor I and protein kinase C activation stimu-
late pulmonary artery smooth muscle cell proliferation through separate but syn-
ergistic pathways. J Cell Physiol. 1990;144:159-65.rdiovascular Surgery c Volume 143, Number 4 973
E
T
/B
S
